Home › Funds › JOHNSON & JOHNSON › MGTX
JOHNSON & JOHNSON position in MGTX
MEIRAGTX HLDGS PLC · Health Care
JOHNSON & JOHNSON reported holding 6,641,064 shares of MGTX (MEIRAGTX HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$73.1M, representing 9.59% of its reported portfolio and ranking #3 among its reported holdings. JOHNSON & JOHNSON has disclosed MGTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JOHNSON & JOHNSON's MGTX position evolved
JOHNSON & JOHNSON first disclosed a stake in MGTX in Q3 2023 at 6,641,064 shares (US$32.6M). The position peaked in Q2 2026 at 6,641,064 shares, worth US$89.7M. Across 13 filings, JOHNSON & JOHNSON held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,641,064 shares valued at US$73.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.64M | $32.61M | New |
| Q4 2023 | 6.64M | $46.62M | Hold |
| Q1 2024 | 6.64M | $40.31M | Hold |
| Q2 2024 | 6.64M | $27.96M | Hold |
| Q3 2024 | 6.64M | $27.69M | Hold |
| Q4 2024 | 6.64M | $40.44M | Hold |
| Q1 2025 | 6.64M | $45.03M | Hold |
| Q2 2025 | 6.64M | $43.90M | Hold |
| Q3 2025 | 6.64M | $54.66M | Hold |
| Q4 2025 | 6.64M | $52.80M | Hold |
| Q1 2026 | 6.64M | $57.51M | Hold |
| Q2 2026 | 6.64M | $89.72M | Hold |
| Q3 2026 | 6.64M | $73.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MGTX and 13F data
MGTX (MEIRAGTX HLDGS PLC) is a Health Care company. 50 other funds we track also report a position in MGTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$145.7M), Sanofi (US$134.2M), Rubric Capital Management LP (US$122.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MGTX
- PERCEPTIVE ADVISORS LLC 10.79M sh · $145.73M · Q2 2026
- Sanofi 12.20M sh · $134.18M · Q3 2026
- Rubric Capital Management LP 9.10M sh · $122.94M · Q2 2026
- Opaleye Management Inc. 3.55M sh · $47.96M · Q2 2026
- 683 Capital Management, LLC 2.30M sh · $31.07M · Q2 2026
- Knoll Capital Management, LLC 1.25M sh · $16.89M · Q2 2026
- Long Focus Capital Management, LLC 1.08M sh · $14.59M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 850.00K sh · $11.48M · Q2 2026
- Privium Fund Management B.V. 208.51K sh · $2.29M · Q3 2026
More on JOHNSON & JOHNSON
FAQ
How long has JOHNSON & JOHNSON held MGTX?
JOHNSON & JOHNSON has disclosed MGTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JOHNSON & JOHNSON's current position in MGTX?
As of Q3 2026, JOHNSON & JOHNSON holds 6.64M shares of MGTX (MEIRAGTX HLDGS PLC), valued at $73.05M, representing 9.59% of its reported portfolio and ranking #3.
Has JOHNSON & JOHNSON been buying or selling MGTX?
In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in MGTX. The position peaked in Q2 2026 at 6.64M shares.
Which other funds hold MGTX?
Other major institutional holders of MGTX include PERCEPTIVE ADVISORS LLC, Sanofi, Rubric Capital Management LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.